The proliferation of antimicrobial resistance (AMR) in low- and middle-income countries is being accelerated by suboptimal prescribing behaviors and a lack of pharmaceutical standardization.

中低收入國家抗生素耐藥性（AMR）的激增，是由於不理想的處方行為以及缺乏藥品標準化所加速的。

The escalation of AMR is significantly influenced by structural deficits in healthcare access. In jurisdictions such as Ghana, a paucity of qualified medical practitioners necessitates reliance on unauthorized vendors, whose distribution of non-standardized antibiotic concoctions facilitates bacterial adaptation. Clinical data from the Korle Bu Teaching Hospital indicates that approximately 60% of patients exhibit resistance to 'Access' category antibiotics, with a critical 4% resistance rate observed for carbapenems, which serve as primary therapeutic options. This trend is mirrored globally; the World Health Organization (WHO) reports that one in six laboratory-confirmed bacterial infections is now resistant, with the highest burden concentrated in low- and middle-income countries.

AMR 的升級受到醫療服務獲取能力結構性缺陷的顯著影響。在如加納等司法管轄區，合格醫療從業人員的匱乏使得民眾不得不依賴未經授權的販賣者，而後者分發的非標準化抗生素組合促進了細菌的適應。來自 Korle Bu 教學醫院的臨床數據顯示，約 60% 的患者對「接取」（Access）類抗生素表現出耐藥性，而作為主要治療方案的碳青霉烯類（carbapenems）則觀察到 4% 的關鍵耐藥率。這一趨勢在全球範圍內都有體現；世界衛生組織（WHO）報告稱，目前每六例經實驗室確認的細菌感染中就有一例具有耐藥性，且最高負擔集中在中低收入國家。

Stakeholder positioning reveals a dichotomy between regulatory prohibition and pragmatic integration. While some nations advocate for the strict enforcement of prescription-only laws, other experts suggest that a rapprochement with informal drug sellers—via education and digital tools like the 'Antibiotic Bandhu' app—may be more efficacious. Furthermore, overprescription is not limited to informal sectors. Research in South Africa demonstrated that 73% of patients with viral symptoms were prescribed antibiotics, a phenomenon attributed to clinical misconceptions among nurses and economic pressures on private physicians to ensure patient retention.

利益相關者的定位揭示了監管禁止與務實整合之間的對立。雖然一些國家主張嚴格執行僅限處方的法律，但其他專家建議，透過教育和如 'Antibiotic Bandhu' App 等數位工具與非正式藥品銷售者達成和解可能會更有效。此外，過度處方並不限於非正式部門。南非的研究表明，73% 具有病毒症狀的患者被開具了抗生素，這一現象被歸因於護理人員的臨床誤解以及私人醫生為了確保患者留存而面臨的經濟壓力。

Technological and semiotic interventions are being proposed to address these systemic failures. The absence of diagnostic infrastructure often forces clinicians to employ empirical treatment cycles without laboratory confirmation. However, the introduction of point-of-care C-reactive Protein (CRP) testing in Kyrgyzstan has demonstrated a quantifiable reduction in unnecessary prescriptions. Simultaneously, the ABACUS project identifies a critical lack of visual differentiation between antibiotics and other pharmaceuticals, leading to widespread patient confusion. Proposed remediations include the standardization of pill morphology and the implementation of QR-code-based labeling to enhance health literacy and ensure adherence to correct dosage and duration.

目前正提出技術和符號學干預措施以解決這些系統性失效。診斷基礎設施的缺失通常迫使臨床醫生在沒有實驗室確認的情況下採取經驗性治療方案。然而，在吉爾吉斯斯坦引入的即時 C-反應蛋白（CRP）檢測已證明能量化地減少不必要的處方。同時，ABACUS 項目指出抗生素與其他藥品之間嚴重缺乏視覺區分，導致患者普遍混淆。擬定的補救措施包括標準化藥丸形態以及實施基於 QR-code 的標籤，以提升健康素養並確保正確的劑量和用藥時間。

Current efforts to combat AMR focus on integrating diagnostic technology, improving pharmaceutical labeling, and transitioning from punitive regulation to the educational integration of informal healthcare providers.

目前對抗 AMR 的努力集中於整合診斷技術、改善藥品標記，以及將懲罰性監管轉向對非正式醫療提供者的教育性整合。